Learning objectives for this course:
• To understand the prostate patient’s journey from suspected cancer to the advanced disease state using the framework of definable clinical states.
• To know in detail the pathologic states, problems of categorisation and clinical needs of patients in each clinical state in the prostate cancer pathway.
• To understand how imaging can help meet clinical priorities and so promote the personalisation of care in the advancing prostate cancer pathway.
• To show how next generation prostate imaging (multiparametric MRI & MR-directed biopsies) and whole body assessments (whole body MRI & PET/CT) with clinical biomarkers, create opportunities to support and refine management pathways of patients.